November 30, 2006
AstraZeneca Less Likely To Be Bought By Glaxo - newratings.com
AstraZeneca Less Likely To Be Bought By Glaxonewratings.com - 3 hours ago0829 GMT [Dow Jones] AstraZeneca (AZN) is less likely to be bought by GlaxoSmithKline (GSK) than in the past, says Sanford Bernstein. … Pfizer Move Could Boost Sector EBIT 5% - DK newratings.comUK Pharmas Boosted By Pfizer News >GSK newratings.comall 3 news articles
Read full story